heart-disease

Documents about heart-disease

• Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)#417439ClinicalTrials.gov
• ABSORB Post-Approval Clinical Study#811000ClinicalTrials.gov
• Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE#824939ClinicalTrials.gov
• Study of Sexual Dysfunction in Patients Included in a Cardiac Rehabilitation Program in Champagne-Ardenne#829308ClinicalTrials.gov
• Frailty and Cognitive Function Assessment of TAVI Patients#829793ClinicalTrials.gov
• Evaluation of Preoperative Acceptance of Proactive Palliative Care Intervention#850191ClinicalTrials.gov
• WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey#851531ClinicalTrials.gov
• 42 U.S.C. § 4362 — Interagency cooperation on prevention of environmental cancer and heart and lung disease#592250US Code (LII)
• 42 U.S.C. § 4362a — Membership of Task Force on Environmental Cancer and Heart and Lung Disease#592251US Code (LII)
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome#848603ClinicalTrials.gov
• Trends and projections of IHD burden attributable to dietary high sodium and kidney dysfunction in G20 countries, 1990–2050#450179PLOS
• Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease.#811281ClinicalTrials.gov
• Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease#850905ClinicalTrials.gov
• Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function#861208ClinicalTrials.gov
• Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)#863833ClinicalTrials.gov
• The value of cardiopulmonary exercise testing in determining severity in patients with both systolic heart failure and COPD#462318RI UFSCar
• CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)#801123ClinicalTrials.gov
• Cardiovascular, Pulmonary and Skeletal Muscle Evaluation Postoperative in Fontan Patients: Effects of Exercise Training#804701ClinicalTrials.gov
• A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study#826934ClinicalTrials.gov
• Cardiovascular Disease Subtypes and Alzheimer's Disease: Phenotypic and Genetic Associations in the UK Biobank and All of Us Research Program#383743Digital Commons @ Michigan Tech
• Validation of MRI Measurement of Cardiac Blood Flow#800229ClinicalTrials.gov
• Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease#839294ClinicalTrials.gov
• Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI)#851046ClinicalTrials.gov
• Paediatric Resuscitation Outcome in Children with Heart Disease (ProCHD): protocol of a Germany-wide multicentre, prospective open registry.#960NCBI PubMed Central
• CardiaTics: An explainable AI integrated heart disease diagnosis model with feature engineering and stacked ensemble approach.#4133NCBI PubMed Central
• Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension#146328ClinicalTrials.gov
• Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs#152370ClinicalTrials.gov
• Coronary artery disease diagnosis with signal processing and machine learning of heart sound signals: a systematic review.#154405NCBI PubMed Central
• Structural Covariance Analysis of Altered Brain Development in Neonates with Congenital Heart Disease After Surgery#158283bioRxiv / medRxiv
• Structural Covariance Analysis of Altered Brain Development in Neonates with Congenital Heart Disease After Surgery#161687Unpaywall
• Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico#162338ClinicalTrials.gov
• Comparative Effectiveness of Telemedicine in Primary Care#267929ClinicalTrials.gov
• Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets#279661ClinicalTrials.gov
• Adaptation of an evidence-based home cardiac rehabilitation programme for people with coronary heart disease in Bangladesh.#285301NCBI PubMed Central
• Sudden fatal anaphylactic reaction to human albumin infusion in a patient with rheumatic heart disease: A case report#306935African Journals Online
• Retinal imaging and supervised learning predict hospitalizations and kidney and heart-lung damage in sickle cell disease.#342493NCBI PubMed Central
• A Network Analysis of Medication Literacy and Associated Psychological Factors in Patients with Coronary Heart Disease and Diabetes.#351352NCBI PubMed Central
• Social network interventions to support cardiac rehabilitation and secondary prevention in the management of people with heart disease#377897Enlighten Publications
• Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment#383817CiNii
• Virtual Diabetes Group Visits Across Health Systems#411283ClinicalTrials.gov
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)#444808ClinicalTrials.gov
• Nocturnal heart rate variability in Parkinson's disease: associations with autonomic dysfunction, cognitive function, and mood symptoms.#457527NCBI PubMed Central
• Cardiac Acute Transitioning Care to Home (CATCH) App Data Repository#801615ClinicalTrials.gov
• Extubation Times in Postoperative Congenital Cardiovascular Surgeries#802906ClinicalTrials.gov
• Comparison of PRISM III, PIM2 and PELOD Scoring Systems#827152ClinicalTrials.gov
• Rotational Atherectomy: Long-term Results From a Single Center Experience#829939ClinicalTrials.gov
• Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control#830319ClinicalTrials.gov
• Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM#834104ClinicalTrials.gov
• Stroke Prevention in Sickle Cell Anemia (STOP 2)#836392ClinicalTrials.gov
• Thiamine Intervention and Coronary Artery Bypass Grafting#836527ClinicalTrials.gov